Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Numinus Wellness Inc NUMIF


Primary Symbol: T.NUMI

Numinus Wellness Inc. is a Canada-based mental health care company. The Company helps people to heal and be well through the development and delivery of mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Company's segments include Clinical Research Operations, Canadian Clinic Network and US Clinic Network. Its Clinical Research Operations is focused on... see more

TSX:NUMI - Post Discussion

Numinus Wellness Inc > $MYND is another to look out for, just filed their patents
View:
Post by SmallCapIntel on Jun 10, 2021 7:22am

$MYND is another to look out for, just filed their patents

This is another really interest psilocybin focused company that is approaching MDD by means of targeting inflammation with a single molecule of psilocybin, meaning there would be no psychoactive trip involved. Clinical trials start later this year. Definitely a cool one to check out if you're looking to beef up your psych exposure. 

 

https://www.newswire.ca/news-releases/mynd-life-sciences-announces-patent-applications-for-depression-and-neuropsychiatric-disorder-drugs-858092843.html

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities